Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
146.94
+1.17 (0.80%)
Nov 20, 2026, 11:55 AM EST - Market open
Palvella Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $246 | Buy | Reiterates | $246 | +67.42% | Nov 20, 2026 |
| BTIG | BTIG | Buy Maintains $215 | Buy | Maintains | $215 | +46.32% | Nov 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $232 | Buy | Reiterates | $232 | +57.89% | Nov 20, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Initiates $228 | Buy | Initiates | $228 | +55.17% | Nov 16, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $232 → $243 | Buy | Reiterates | $232 → $243 | +65.37% | Nov 9, 2026 |
| Raymond James | Raymond James | Buy Maintains $226 → $230 | Buy | Maintains | $226 → $230 | +56.53% | Nov 6, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $207 | Buy | Maintains | $207 | +40.87% | Nov 6, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $205 → $230 | Buy | Maintains | $205 → $230 | +56.53% | Nov 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.